Development of experimental cerebral malaria is independent of IL-23 and IL-17

Biochemical and Biophysical Research Communications

Volumn 402, Issue 4, 2010, Pages 790-795

  Ishida, Hidekazu ^a,b   Matsuzaki Moriya, Chikako ^a   Imai, Takashi ^b   Yanagisawa, Kunio ^b   Nojima, Yoshihisa ^c   Suzue, Kazutomo ^b   Hirai, Makoto ^b   Iwakura, Yoichiro ^d   Yoshimura, Akihiko ^e   Hamano, Shinjiro ^f   Shimokawa, Chikako ^f   Hisaeda, Hajime ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cerebral malaria; IL 17; IL 23; Immune responses; Malaria

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRAIN MALARIA; BRAIN SEQUESTERED LEUKOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATORY DISEASE; LEUKOCYTE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPLEEN CELL; TH17 CELL; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-17; INTERLEUKIN-23; MALARIA, CEREBRAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM FALCIPARUM;

MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 78649476031     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.114     Document Type: Article

References (33)

1. Good M.F., Xu H., Wykes M., Engwerda C.R. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 2005, 23:69-99.
2. MacPherson G.G., Warrell M.J., White N.J., Looareesuwan S., Warrell D.A. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985, 119:385-401.
3. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2002, 415:673-679.
4. Roll Back Malaria: spotlight on Africa, TDR News (2000) 10, 15.
5. Snow R.W., Trape J.F., Marsh K., past The present and future of childhood malaria mortality in Africa. Trends Parasitol. 2001, 17:593-597.
6. van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006, 22:503-508.
7. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 2007, 25:221-242.
8. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
9. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202:96-105.
10. Sun W., He X., Guo Z., Wang Q., Li X., Rayner J., Zhang L., Wang J., Cao X. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production. Immunol. Lett. 2004, 94:191-199.
11. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
12. + T cell responses after vaccination and during mycobacterium tuberculosis challenge. Nat. Immunol. 2007, 8:369-377.
13. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
14. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
15. Tato C.M., Cua D.J. Reconciling id, ego, and superego within interleukin-23. Immunol. Rev. 2008, 226:103-111.
16. Knauer J., Siegemund S., Muller U., Al-Robaiy S., Kastelein R.A., Alber G., Straubinger R.K. Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells. FEMS Immunol. Med. Microbiol. 2007, 49:353-363.
17. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., Saris C.J., O'Shea J.J., Hennighausen L., Ernst M., Hunter C.A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
18. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 2007, 178:5779-5788.
19. Engwerda C., Belnoue E., Gruner A.C., Renia L. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 2005, 297:103-143.
20. Chen L., Zhang Z., Sendo F. Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clin. Exp. Immunol. 2000, 120:125-133.
21. deWalick S., Amante F.H., McSweeney K.A., Randall L.M., Stanley A.C., Haque A., Kuns R.D., MacDonald K.P., Hill G.R., Engwerda C.R. Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 2007, 178:6033-6037.
22. Miu J., Mitchell A.J., Muller M., Carter S.L., Manders P.M., McQuillan J.A., Saunders B.M., Ball H.J., Lu B., Campbell I.L., Hunt N.H. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 2008, 180:1217-1230.
23. + T cells in experimental cerebral malaria. J. Immunol. 2002, 169:6369-6375.
24. Voza T., Vigario A.M., Belnoue E., Gruner A.C., Deschemin J.C., Kayibanda M., Delmas F., Janse C.J., Franke-Fayard B., Waters A.P., Landau I., Snounou G., Renia L. Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp. Infect. Immun. 2005, 73:4777-4786.
25. Hearn J., Rayment N., Landon D.N., Katz D.R., de Souza J.B. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 2000, 68:5364-5376.
26. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
27. Maynard C.L., Weaver C.T. Intestinal effector T cells in health and disease. Immunity 2009, 31:389-400.
28. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., Kolls J.K., Flavell R.A. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 2009, 10:603-609.
29. + regulatory T cells. Nat. Med. 2004, 10:29-30.
30. + T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 2003, 33:175-183.
31. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
32. Bhalla A., Suri V., Singh V. Malarial hepatopathy. J. Postgrad. Med. 2006, 52:315-320.
33. van de Veerdonk F.L., Gresnigt M.S., Kullberg B.J., van der Meer J.W., Joosten L.A., Netea M.G. Th17 responses and host defense against microorganisms: an overview. BMB Rep. 2009, 42:776-787.